Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the fields of cancer metabolism and inborn errors of metabolism, today announced that preclinical and clinical data from Agios’ cancer metabolism programs will be highlighted at the American Association for Cancer Research (AACR) Annual Meeting taking place April 5-9, 2014 in San Diego, Calif.
Help employers find you! Check out all the jobs and post your resume.
